NVP-LCQ195 (AT9311) is a potent, selective small-molecule inhibitor of cyclin-dependent kinases 1, 2, 3, and 5 with IC50 values in the low nanomolar range. It is a valuable research tool for studying cell cycle progression, neuronal function, and apoptosis in vitro, and has been utilized in preclinical cancer research models.